GlassScriptPhysician profile
Brian Vahjen
NPI 1649398579
$2,986.36
in general payments reported to CMS, 2019-2025
28 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $84.74 · 2021: $371 · 2022: $188 · 2023: $622 · 2024: $832 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,045.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,311.33 | 2019-2025 | Clareon, Rocklatan, Unity |
| New World Medical,INC. | $222.49 | 2023-2024 | Kahook Dual Blade, Streamline, Clearpath |
| Tarsus Pharmaceuticals, INC. | $165.42 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $149.12 | 2022-2025 | Tyrvaya |
| Bausch & Lomb Americas INC. | $143.54 | 2022-2025 | Vyzulta, Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $120.40 | 2019-2021 | |
| Abbvie INC. | $102.86 | 2022-2025 | |
| Notal Vision, INC. | $101.96 | 2025 | Foresee Home |
| Sun Pharmaceutical Industries INC. | $90.49 | 2019-2020 | |
| Johnson & Johnson Surgical Vision, INC. | $70.43 | 2021-2025 | Tecnis Iol, Tecnis Iol |
| Sight Sciences, INC. | $51.88 | 2021-2024 | Omni Surgical System |
| Ocular Therapeutix, INC. | $44.43 | 2021 | |
| Genentech USA, INC. | $43.03 | 2022-2023 | Vabysmo |
| Allergan, INC. | $40.73 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $39.00 | 2023-2024 | Eylea, Eylea Hd |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $36.95 | 2024-2025 | Tepezza |
| Rayner Intraocular Lenses Limited | $36.82 | 2023 | Rayone Emv, Omidria, Rayone Aspheric |
| Shire North American Group INC | $33.15 | 2019 | |
| Rxsight INC | $24.84 | 2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Harrow Eye, LLC | $22.45 | 2025 | Vevye |
| Mallinckrodt Enterprises LLC | $19.79 | 2019 | |
| Dompe US, INC. | $19.18 | 2024 | Oxervate |
| Novartis Pharmaceuticals Corporation | $18.80 | 2019 | |
| Glaukos Corporation | $16.92 | 2024 | Radius |
| Biotissue Holdings INC. | $16.58 | 2022 | |
| Aerie Pharmaceuticals, INC. | $15.73 | 2019 | |
| Lumenis, INC | $14.51 | 2021 | |
| Johnson & Johnson Vision Care, INC. | $13.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Vahjen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.